Literature DB >> 22367428

Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients?

Nuggehally R Srinivas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22367428     DOI： 10.1007/s00228-012-1242-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  14 in total

1.  Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study.

Authors:  Ravindra Arya; Sheffali Gulati; Madhulika Kabra; Jitendra K Sahu; Veena Kalra
Journal:  Epilepsia       Date:  2011-01-28       Impact factor: 5.864

Review 2.  Benzodiazepines for prolonged seizures.

Authors:  Mark Anderson
Journal:  Arch Dis Child Educ Pract Ed       Date:  2010-12       Impact factor: 1.309

3.  Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers.

Authors:  Mark Anderson; Parag Tambe; Helen Sammons; Hussain Mulla; Richard Cole; Imti Choonara
Journal:  Eur J Clin Pharmacol       Date:  2011-08-12       Impact factor: 2.953

4.  Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.

Authors:  Andrew Finn; Jason Collins; Robert Voyksner; Celeste Lindley
Journal:  J Clin Pharmacol       Date:  2005-12       Impact factor: 3.126

5.  Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus.

Authors:  James M Chamberlain; Edmund V Capparelli; Kathleen M Brown; Cheryl W Vance; Kathleen Lillis; Prashant Mahajan; Richard Lichenstein; Rachel M Stanley; Colleen O Davis; Stephen Gordon; Jill M Baren; John N van den Anker
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

6.  Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration.

Authors:  D P Wermeling; J L Miller; S M Archer; J M Manaligod; A C Rudy
Journal:  J Clin Pharmacol       Date:  2001-11       Impact factor: 3.126

Review 7.  The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party.

Authors:  R Appleton; I Choonara; T Martland; B Phillips; R Scott; W Whitehouse
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

8.  Intra- and interindividual variabilities in the pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a cross-study analysis.

Authors:  Andrew Davies; Andrew Finn; Ignacio Tagarro
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

9.  Fentanyl buccal tablet for the treatment of breakthrough pain: pharmacokinetics of buccal mucosa delivery and clinical efficacy.

Authors:  Mona Darwish; Ehab Hamed; John Messina
Journal:  Perspect Medicin Chem       Date:  2010-06-04

10.  Bioavailability of dexmedetomidine after extravascular doses in healthy subjects.

Authors:  Markku Anttila; Jani Penttilä; Antti Helminen; Lauri Vuorilehto; Harry Scheinin
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.